ANI Pharmaceuticals Inc (ANIP)
64.59
-0.89
(-1.36%)
USD |
NASDAQ |
Apr 18, 16:00
64.56
-0.02
(-0.04%)
After-Hours: 20:00
ANI Pharmaceuticals Total Liabilities (Quarterly): 446.82M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 446.82M |
| September 30, 2023 | 435.20M |
| June 30, 2023 | 424.87M |
| March 31, 2023 | 425.74M |
| December 31, 2022 | 421.55M |
| September 30, 2022 | 402.44M |
| June 30, 2022 | 414.38M |
| March 31, 2022 | 398.75M |
| December 31, 2021 | 412.86M |
| September 30, 2021 | 279.05M |
| June 30, 2021 | 288.24M |
| March 31, 2021 | 260.13M |
| December 31, 2020 | 265.49M |
| September 30, 2020 | 267.48M |
| June 30, 2020 | 274.05M |
| March 31, 2020 | 281.06M |
| December 31, 2019 | 244.00M |
| September 30, 2019 | 243.64M |
| June 30, 2019 | 239.25M |
| March 31, 2019 | 234.68M |
| December 31, 2018 | 233.34M |
| September 30, 2018 | 246.98M |
| June 30, 2018 | 239.07M |
| March 31, 2018 | 238.38M |
| December 31, 2017 | 237.38M |
| Date | Value |
|---|---|
| September 30, 2017 | 187.67M |
| June 30, 2017 | 182.67M |
| March 31, 2017 | 184.93M |
| December 31, 2016 | 153.22M |
| September 30, 2016 | 150.55M |
| June 30, 2016 | 144.22M |
| March 31, 2016 | 131.41M |
| December 31, 2015 | 125.18M |
| September 30, 2015 | 127.38M |
| June 30, 2015 | 120.62M |
| March 31, 2015 | 121.24M |
| December 31, 2014 | 119.77M |
| September 30, 2014 | 8.145M |
| June 30, 2014 | 3.828M |
| March 31, 2014 | 4.56M |
| December 31, 2013 | 3.538M |
| September 30, 2013 | 6.597M |
| June 30, 2013 | 6.163M |
| March 31, 2013 | 9.326M |
| December 31, 2012 | 10.59M |
| September 30, 2012 | 10.92M |
| June 30, 2012 | 16.37M |
| March 31, 2012 | 16.58M |
| December 31, 2011 | 24.56M |
| September 30, 2011 | 30.74M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
239.25M
Minimum
Jun 2019
446.82M
Maximum
Dec 2023
338.16M
Average
288.24M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| ADMA Biologics Inc | 193.98M |
| Ligand Pharmaceuticals Inc | 86.30M |
| Dentsply Sirona Inc | 4.076B |
| Allogene Therapeutics Inc | 130.60M |
| Vanda Pharmaceuticals Inc | 103.53M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 904.42M |
| Shareholders Equity (Quarterly) | 457.60M |
| Debt to Equity Ratio | 0.6243 |
| Current Ratio | 3.573 |
| Net Debt Paydown Yield | 0.02% |